In an accompanying manuscript, we describe preclinical studies in obese mice and non-human primates showing that GDF8 and ActA mAbs in the setting of GLP1-induced weight loss can maintain and even increase muscle mass, with associated metabolic benefit including reduced adiposity, thus providing a potentially better approach to weight loss and maintenance 23 , consistent with the findings observed when treating obese mice with bimagrumab and a GLP1-receptor agonist 24
We will also examine whether changes in body composition, lean mass, dietary protein intake, physical activity, and sleep patterns influence these skeletal responses
Its the latest move in a price war with Denmarks Novo Nordisk, which is making it significantly less expensive for people to start the blockbuster medicines
Users frequently report a significant drop in "food noise" and late-night cravings within the very first 2 weeks
Yes, you can, but we would recommend that you let your prescriber make that choice for you
PlexusDx serves all 50 states without requiring insurance, and the medications are HSA/FSA eligible